|
Welcome, friends. Nearly 30 years ago, a landmark study called ETDRS changed the course of vision care and treatment. ETDRS, or the Early Treatment Diabetic Retinopathy Study, was a randomized clinical trial meant to aid patients with non-proliferative or early proliferative "diabetic retinopathy". It was historic and incredibly important to vision care and remains so today. Did you know that Precision Vision was involved from the very beginning? Read on. CONTENTS |
||||||||||||
Precision Vision and ETDRSETDRS Background ETDRS stands for the Early Treatment Diabetic Retinopathy Study. The randomized ETDRS clinical trial was created to evaluate the effectiveness of "argon laser photocoagulation" and "aspirin treatment" in patients with non-proliferative or early proliferative "diabetic retinopathy". Doctors recruited 3,711 patients and followed their treatments and progress for a 4 year minimum to study treatment risks and benefits. Before this first large multi-center study could launch, new visual acuity charts had to be established. Previous visual acuity tests, including the Snellen acuity test and Sloan acuity test, were not adequately standardized for use at many clinical centers. The development of standardized charts that later would become known as "ETDRS charts" began in 1982 by Frederick L. Ferris III, M.D., Aaron Kassoff, M.D., George H. Bresnick, M.D. and Ian Bailey, O.D., with results published in the American Journal of Ophthalmology. The work done preparing for this study helped to create important testing standardizations, including standard visual acuity eye charts and illuminator cabinets that ensure proper lighting conditions to ensure accurate and repeatable test results. Today, ETDRS acuity testing is the recognized “Gold” standard worldwide for We recently discussed the ETDRS with some of the doctors involved - August Colenbrander, M.D. and Dr. Frederick L. Ferris III, M.D. - and would like to share some of their memories with you. August Colenbrander, M.D. - Affiliate Senior Scientist
Dr. Frederick L. Ferris III, M.D. - Director, Division of Epidemiology and
Precision Vision's Role in ETDRS Precision Vision was called upon to develop the first commercially viable trans-illuminated charts and cabinets for ETDRS. Today, these products are still considered the world standard used in research, education and clinical settings everywhere. Illumination standards for visual acuity testing were set by the first major ETDRS clinical trial. This retro-illuminated cabinet is still in use today and maintains a luminance level of 180 cd/m2. Each cabinet is set up with 2 fluorescent lamps, each lamp then incorporates a fenestrated sleeve (diffuser) to control the light level for very uniform illumination across the charts. Replacement of the lamp is simple and inexpensive. The lamps will last for years under normal conditions but they are typically replaced annually for clinical trials. The cabinet has storage in the back for quick chart access. A 5-leg caster base can be obtained for mobility or the cabinets can wall mounted. We are deeply proud to be a part of such a landmark study, and continue to work with incredible doctors and researchers in the eye care industry. Today, we are developing a newer version of the Original ETDRS Illuminator Cabinet™. This model will include additional features and will include a panel illuminated with LEDs. It will be a fraction of the depth of the existing cabinet which will improve its office appeal and greatly reduce shipping costs. We promise to keep you posted of our progress on this project. |
||||||||||||
Featured ProductsETDRS Illuminator Cabinet™ and Accessories
National Eye Institute and FDA approved and recommended. Standardized uniform retro illumination for all 62 x 65cm (24.5 x 25.5 in.) ETDRS style charts. Learn more about the ETDRS Illuminator Cabinet™ and Accessories Original Series ETDRS Charts
The only standardized format accepted in studies sponsored by the National Eye Institute. Designed for use in clinical studies and low vision evaluations where accurate and repeatable visual acuity measurements are required. Geometric progression in letter size from line to line, each line is of equal difficulty. |
||||||||||||
Upcoming MeetingsVisit Precision Vision will be at the following meetings.
|
||||||||||||
Share Your Stories With Us!Precision Vision® wants to hear your stories. Tell us how you are impacting the industry. Do you have an interesting story to share about a Precision Vision® product? Contact us and we may use it in a future newsletter. |
||||||||||||
|
944 First Street | La Salle, IL 61301 | USA | PHONE: 815.223.2022 | FAX: 815.223.2224 To ensure you always receive mailings from Precision Vision® please If you do not want to receive any future mailings from Precision Vision® click to Unsubscribe. |





